Hybrid 18F-FDG PET-MRI of the hand in rheumatoid arthritis: initial results

Clin Rheumatol. 2011 Sep;30(9):1247-50. doi: 10.1007/s10067-011-1777-3. Epub 2011 May 18.

Abstract

18F-fluorodeoxyglucose PET (18F-FDG PET) is highly sensitive to inflammatory changes within the synovial tissue in rheumatoid arthritis (RA). However, the highest spatial resolution for soft tissue can be achieved with MRI. Here, we report on the first true hybrid PET-MRI examination of the hand in early RA exploiting the advantages of both modalities. PET-MRI was performed with a prototype of an APD-based magneto-insensitive BrainPET detector (Siemens Healthcare, Erlangen, Germany) operated within a standard 3T MR scanner (MAGNETOM Trio, Siemens). PET images were normalized, random, attenuation and scatter-corrected, iteratively reconstructed and calibrated to yield standardized uptake values (SUV) of 18F-FDG uptake. T1-weighted TSE in coronal as well as sagittal orientation prior to and following Gadolinium administration were acquired. Increased 18F-FDG uptake was present in synovitis and tenovaginitis as identified on contrast-enhanced MRI. The tracer distribution was surrounding the metacarpophalangeal joints II and III. Maximum SUV of 3.1 was noted. In RA, true hybrid 18F-FDG PET-MRI of the hand is technically feasible and bears the potential to directly visualize inflammation.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Fluorodeoxyglucose F18* / pharmacokinetics
  • Hand Joints / diagnostic imaging
  • Hand Joints / metabolism
  • Hand Joints / pathology*
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Middle Aged
  • Osteoarthritis / diagnosis*
  • Osteoarthritis / metabolism
  • Positron-Emission Tomography / methods*
  • Radiography
  • Radiopharmaceuticals* / pharmacokinetics
  • Synovial Membrane / diagnostic imaging
  • Synovial Membrane / pathology
  • Synovitis / diagnosis
  • Synovitis / metabolism

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18